BeOne Medicines
ONC
#636
Rank
โ‚ฌ31.46 B
Marketcap
284,34ย โ‚ฌ
Share price
-1.91%
Change (1 day)
50.16%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Market capitalization of BeOne Medicines (ONC)

Market cap: โ‚ฌ31.46 Billion

As of December 2025 BeOne Medicines has a market cap of โ‚ฌ31.46 Billion. This makes BeOne Medicines the world's 636th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BeOne Medicines from 2016 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ31.46 B59.87%
2024โ‚ฌ19.68 B10.36%
2023โ‚ฌ17.83 B-24.79%
2022โ‚ฌ23.70 B-3.38%
2021โ‚ฌ24.53 B27.53%
2020โ‚ฌ19.24 B110.98%
2019โ‚ฌ9.12 B24.85%
2018โ‚ฌ7.30 B96.96%
2017โ‚ฌ3.70 B223.87%
2016โ‚ฌ1.14 B

End of Day market cap according to different sources

On Dec 4th, 2025 the market cap of BeOne Medicines was reported to be:

โ‚ฌ31.46 Billion
by Nasdaq info icon info icon
โ‚ฌ31.46 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Onconova Therapeutics
ONTX
โ‚ฌ17.93 M-99.94%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
โ‚ฌ0.91 B-97.08%๐Ÿ‡บ๐Ÿ‡ธ USA